Ignite Creation Date:
2025-12-26 @ 10:56 AM
Ignite Modification Date:
2026-04-22 @ 2:44 PM
Study NCT ID:
NCT05422508
Status:
RECRUITING
Last Update Posted:
2024-01-24
First Post:
2022-05-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination
Sponsor:
Green Cross Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MG1111_VAR_P0201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None